(PharmaNewsWire.Com, March 24, 2017 ) Increasing research applications and growing demand for high consumption of crude oil are some of the key factors driving the market growth. Population growth and industrialization are some of the key drivers in this market growth. Furthermore, growing population and rapid industrialization generate an increase in demand of energy. Increasing energy demand leads to higher production of oil which in turn, leads to the growth of low dosage hydrate inhibitors. However, cost effective, continuous fabrication of crude oil and low dosage hydrate inhibitor usage are the restraints hampering this market growth. North American region is expected to register a significant growth for these products over the forecast period.
Some of the key players in the market include Ashland, Halliburton and NALco (ECOLAB COMPANY), NEFTECHIM Technologies, JSC Gazprom Neftekhim Salavat, Clariant Chemicals, GasHydrate LLC, Evonik, Ecolab, ClariantOilServices, Yara International, Stella Maris LLC, LEWA ,Woodview Technology and BASF.
Regions Covered: - North America - US - Canada - Mexico - Europe - Germany - France - Italy - UK - Spain - Rest of Europe - Asia Pacific - Japan - China - India - Australia - New Zealand - Rest of Asia Pacific - Rest of the World - Middle East - Brazil - Argentina - South Africa - Egypt
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
